Search

everythinglearnresearchcommunity

for

Search:↓

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Electrochemotherapy successfully treated skin tumors in cats without recurrence.

Controlling transposable elements is crucial for successful tissue regeneration.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

The tool kit helps transit agencies ensure safety by managing employees' medication use.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

TAF can be identified by excessive skin thickening and clogged hair follicles, helping distinguish it from similar skin conditions.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Controlling Tslp can improve health in AEC syndrome patients.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

The gene Tfap2b is essential for creating a type of stem cell in zebrafish that can become different pigment cells.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

The combined treatments were highly effective for improving atrophic acne scars.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The Hair Cell Analysis Toolbox automates and improves the analysis of cochlear hair cells using machine learning.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

A pathway helps maintain long telomeres in both stem and cancer cells.